Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher
Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher
Clearmind Medicine Inc. (NASDAQ:CMND) shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge behavior regulator program through the granting of patent approval in Hong Kong by the Hong Kong Patent Office.
Clearmind Medicine股份有限公司（納斯達克股票代碼：CMND）的股票週五交易較高，因公司宣佈其通過香港專利局在香港獲得專利批准的專有MEAI型暴飲暴食行爲調節劑項目有進展。
The Details:
細節：
Clearmind said the allowed claims are directed to use a primary amine aminoindan compound to regulate binge behavior, including primary amine aminoindan compounds beyond 5-methoxy-2-aminoindan (MEAI), the company's innovative psychedelic molecule.
Clearmind表示，允許的權利要求是針對使用一種主要氨基異氮基化合物來調節暴飲暴食行爲，包括超過5-甲氧基-2-氨基異氮基化合物（MEAI）的主要氨基異氮基化合物，這是該公司創新的致幻分子。
MEAI is a psychoactive molecule that reduces the desire to consume alcoholic beverages and provides a slight euphoric, alcohol-like experience. Clearmind's MEAI-based flagship treatment focuses on Alcohol Use Disorder and weight loss. MEAI may also be used to treat binge drinking, according to Clearmind.
MEAI是一種精神活性分子，可以減少飲酒慾望並提供輕微的欣快感、類似於飲酒的體驗。Clearmind的MEAI-based旗艦治療重點關注酒精使用障礙和減重，同時，MEAI也可以用於治療暴飲暴食症。
The company has 28 granted patents across 18 patent families, with patents granted in major jurisdictions such as the U.S., Europe, China, India and Hong Kong.
該公司在18個專利族中擁有28項授權專利，在美國，歐洲，中國，印度和香港等主要司法轄區獲得了專利授權。
Clearmind shares are moving on heavy trading volume following the company's announcement with more than 70.7 million shares already traded in Friday's session. According to data from Benzinga Pro, the stock's 100-day average volume is less than 1.3 million shares.
Clearmind的股票成交量較大，其股票在宣佈後的週五交易量超過7070萬股。根據Benzinga Pro的數據，該股票的100天平均成交量不到130萬股。
Related News: Elon Musk's Tesla Pay Package Saga Continues: Latest Developments
相關資訊：埃隆·馬斯克的特斯拉薪酬套路仍在繼續：最新動態
How To Buy CMND Stock:
如何購買CMND的股票：
By now you're likely curious about how to participate in the market for Clearmind Medicine – be it to purchase shares, or even attempt to bet against the company.
現在您可能會好奇如何參與Clearmind Medicine的市場，無論是購買股票，還是甚至嘗試對公司進行投注。
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
購買股票通常是通過證券帳户進行的。您可以在這裏找到可能的交易平台列表。許多交易平台將允許您購買“碎股”，這樣可以購買部分股票而非整張股票。例如，有些股票，如伯克希爾-哈撒韋公司或亞馬遜公司，可能需要數千美元才能持有一股。但是，如果您只想投資其中一小部分，券商將允許您這樣做。
In the the case of Clearmind Medicine, which is trading at $1.71 as of publishing time, $100 would buy you 58.48 shares of stock.
在Clearmind Medicine的情況下，其股票價格爲1.71美元，購買100美元的股票將買到58.48股股票。
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to 'go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
如果您想押注股票下跌，流程就更爲複雜了。您需要訪問期權交易平台，或者找一家券商讓您通過借出股票進行“開空”操作（借股出售）。您可以在該資源中了解到賣空股票的過程。否則，如果您的券商允許您交易期權，您可以在當前股票交易價以上的執行價上購買看跌期權或者賣出看漲期權 - 無論哪種情況都可以讓您從股票價格下跌中獲利。
CMND Price Action: According to Benzinga Pro, Clearmind Medicine shares are up 29.1% at $1.73 at the time of publication Friday.
CMND股價走勢：據Benzinga Pro指出，Clearmind Medicine股票價格上漲了29.1％，至本週五1.73美元。
Image: Shutterstock
圖片：shutterstock
譯文內容由第三人軟體翻譯。